Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and deadliest cancer worldwide. The primary reasons for this are the lack of early detection methods and targeted therapy. Emerging evidence highlights the metabolic addiction of cancer cells as a potential target to combat PDAC....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu-Huei, Hu, Chun-Mei, Hsu, Yuan-Sheng, Lee, Wen-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508091/
https://www.ncbi.nlm.nih.gov/pubmed/36151074
http://dx.doi.org/10.1038/s41419-022-05259-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508091/
https://www.ncbi.nlm.nih.gov/pubmed/36151074
http://dx.doi.org/10.1038/s41419-022-05259-w

Ejemplares similares